Organigram Global (OGI) Return on Invested Capital (2019 - 2025)

Organigram Global (OGI) posted quarterly Return on Invested Capital of 2.12% for Q1 2025, down 14719.54% quarter-over-quarter from 0.01% in Q3 2020.

Organigram Global (OGI) Return on Invested Capital (2019 - 2025) Analysis & Trends

Organigram Global (OGI) has reported Return on Invested Capital for 3 consecutive years, with 2.12% the latest figure, recorded in Q1 2025.

In Q1 2025, Return on Invested Capital changed N/A year-over-year to 2.12%; the TTM figure through Mar 2025 stood at 2.12% (changed N/A YoY), while the FY2020 annual figure was 0.02%, down 2.0% from the prior year.
Return on Invested Capital retreated to 2.12% in Q1 2025 per OGI's latest filing, from 0.01% in the prior quarter.
Across five years, Return on Invested Capital topped out at 2.12% in Q1 2025 and bottomed at 2.12% in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-	-
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn	0.00%
3	Zoetis	31.78 Bn	30.11 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.71 Bn	22.91 Bn	5.10 Bn	0.00%
5	United Therapeutics	22.25 Bn	19.59 Bn	683.80 Mn	-
6	Viatris	18.72 Bn	17.83 Bn	1.46 Bn	0.00%
7	Neurocrine Biosciences	15.57 Bn	15.18 Bn	935.80 Mn	-
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn	0.03%
9	Dr Reddys Laboratories	10.14 Bn	9.97 Bn	-	-
10	Organigram Global	150.72 Mn	150.60 Mn	28.97 Mn	48,208,586,622,222.69%

Download Data